Fiducial marker implantation using convex probe EBUS and autologous blood

Stereotactic body radiotherapy (SBRT) has evolved as an improved treatment strategy for early-stage lung cancer in individuals who are unfit for surgery[1][1] and for oligometastatic disease.[2][2] Precision targeting of small lesions for high-dose radiation is key. This is frequently facilitated